02.15.21

Nicox’s US Licensee Eyevance Expands U.S. Promotion of Zerviate In Agreement with Hikma

Source: Nicox

12.30.20

Nicox’s Partner Ocumension Therapeutics Initiates Zerviate Phase 3 Clinical Trial in China

08.12.20

Nicox Partners Zerviate in the Gulf and Arab Markets

Source: Nicox

07.10.20

Nicox Partner Ocumension Completes Successful Hong Kong IPO

Source: Nicox

04.17.20

Nicox Provides Business Update and Financial Highlights

Source: Nicox

03.30.20

Eyevance Pharmaceuticals Launches Zerviate in the United States

Source: Eyevance Pharmaceuticals

03.11.20

Nicox Updates on Zerviate Progress in China and Expands the Countries of its Agreement with Ocumension Therapeutics

Source: Nicox

12.06.19

Nicox Signs Agreement for Zerviate in South Korea

Source: Nicox

09.17.19

Nicox Provides Business Update and Upcoming Milestones

Source: Nicox

07.09.19

Nicox Receives $3 Million Milestone Payment From Eyevance for Zerviate in the US

Source: Nicox

View more stories